Exogenus Unveils Standardized QC Workflow for Cord Blood EV Therapy
Exogenus Therapeutics, a company developing umbilical cord blood–derived extracellular vesicles for inflammatory and degenerative conditions, has built a quality-control workflow that replaces costly whole-molecular profiling with a standardized, sustainable assay … Read More